Key Research Findings Summary

A scientific summary covering preclinical ARA-290 (cibinetide) research, focusing on IRR binding, neuroinflammation, and ischemia-reperfusion models.

• ARA-290 (Cibinetide) research profile

≥99% purity, third-party COA verified, manufactured in the USA. For research use only — not for human or veterinary use.